What is Prime Medicine's other commercial liabilities?

Prime Medicine (PRME) reported other commercial liabilities of $8.1M in Q1 2026.

How has Prime Medicine's other commercial liabilities changed year-over-year?

Prime Medicine's other commercial liabilities decreased by 11.9% year-over-year, from $9.19M to $8.1M.

What is the long-term trend for Prime Medicine's other commercial liabilities?

Over 4 years (2021 to 2025), Prime Medicine's other commercial liabilities has grown at a -23.7% compound annual growth rate (CAGR), from $37.19M to $12.6M.

Prime Medicine PRME Other Commercial Liabilities

Other Commercial Liabilities at other companies

Vertex PharmaceuticalsVRTX

——

Intellia TherapeuticsNTLA

——

CRISPR TherapeuticsCRSP

——

Sarepta Therapeutics, Inc.SRPT

——

MeiraGTx Holdings plcMGTX

——

4D Molecular TherapeuticsFDMT

——

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's other commercial liabilities?: Prime Medicine (PRME) reported other commercial liabilities of $8.1M in Q1 2026.
How has Prime Medicine's other commercial liabilities changed year-over-year?: Prime Medicine's other commercial liabilities decreased by 11.9% year-over-year, from $9.19M to $8.1M.
What is the long-term trend for Prime Medicine's other commercial liabilities?: Over 4 years (2021 to 2025), Prime Medicine's other commercial liabilities has grown at a -23.7% compound annual growth rate (CAGR), from $37.19M to $12.6M.